DrugPatentWatch Database Preview
Drugs in Development Information for Gimeracil
Email this page to a colleague
» See Plans and PricingWhat is the drug development status for Gimeracil?
Gimeracil is an investigational drug.
There have been 63 clinical trials for Gimeracil.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2016.
The most common disease conditions in clinical trials are Stomach Neoplasms, Pancreatic Neoplasms, and Carcinoma. The leading clinical trial sponsors are Taiho Oncology, Inc., Fudan University, and Quintiles, Inc.
There are one hundred and sixteen US patents protecting this investigational drug and nine hundred and sixty-four international patents.
Summary for Gimeracil
| US Patents | 116 |
| International Patents | 964 |
| US Patent Applications | 196 |
| WIPO Patent Applications | 101 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2016-09-01) |
| Vendors | 88 |
Recent Clinical Trials for Gimeracil
| Title | Sponsor | Phase |
|---|---|---|
| Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer | ACT Genomics | Phase 2 |
| Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer | Ono Pharmaceutical Co. Ltd | Phase 2 |
| Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer | TTY Biopharm | Phase 2 |
Clinical Trial Summary for Gimeracil
Top disease conditions for Gimeracil
Top clinical trial sponsors for Gimeracil
US Patents for Gimeracil
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Gimeracil | Start Trial | Metal-salen complex compound, local anesthetic and antineoplastic drug | IHI Corporation (Tokyo, JP) Ishikawa; Yoshihiro (Tokyo, JP) | Start Trial |
| Gimeracil | Start Trial | Multimodal silica-based nanoparticles | Start Trial | |
| Gimeracil | Start Trial | Device and method for drug evaluation and local treatment | Kibur Medical, Inc. (Boston, MA) | Start Trial |
| Gimeracil | Start Trial | Synergistic enhancement of 5-fluorouracil cytotoxicity by deoxyuridine analogs in cancer cells | STC.UNM (Albuquerque, NM) | Start Trial |
| Gimeracil | Start Trial | Pharmaceutical compositions comprising POH derivatives | NeOnc Technologies, inc. (Los Angeles, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Gimeracil
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Gimeracil | China | 103781760 | 2031-06-13 | Start Trial |
| Gimeracil | European Patent Office | 2738158 | 2031-06-13 | Start Trial |
| Gimeracil | Japan | 2013001646 | 2031-06-13 | Start Trial |
| Gimeracil | Japan | 5873656 | 2031-06-13 | Start Trial |
| Gimeracil | Russian Federation | 2013156414 | 2031-06-13 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
